Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen S Yang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in miceChristine B Yoo, Jody C Chuang, Hyang-Min Byun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium TrialAnn M Mohrbacher, Allen S Yang, Susan Groshen, et al.
Cancer Research|February 7, 2007
Changes in DNA methylation patterns in subjects exposed to low-dose benzeneValentina Bollati, Andrea Baccarelli, Lifang Hou, et al.
Cancer|April 8, 2014
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopeniaAristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
Plos One|May 4, 2007
LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instabilityMarcos R H Estécio, Vazganush Gharibyan, Lanlan Shen, et al.
Cancer Research|May 19, 2006
DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemiaAllen S Yang, Ketan D Doshi, Sang-Woon Choi, et al.
International Journal of Epidemiology|September 18, 2010
Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysisZhong-Zheng Zhu, Lifang Hou, Valentina Bollati, et al.
Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
Blood|June 24, 2009
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignanciesTamer E Fandy, James G Herman, Patrick Kerns, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Long-term epigenetic therapy with oral zebularine has minimal side effects and prevents intestinal tumors in miceChristine B Yoo, Jody C Chuang, Hyang-Min Byun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium TrialAnn M Mohrbacher, Allen S Yang, Susan Groshen, et al.
Cancer Research|February 7, 2007
Changes in DNA methylation patterns in subjects exposed to low-dose benzeneValentina Bollati, Andrea Baccarelli, Lifang Hou, et al.
Cancer|April 8, 2014
Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopeniaAristoteles Giagounidis, Ghulam J Mufti, Pierre Fenaux, et al.
Plos One|May 4, 2007
LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instabilityMarcos R H Estécio, Vazganush Gharibyan, Lanlan Shen, et al.
Cancer Research|May 19, 2006
DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemiaAllen S Yang, Ketan D Doshi, Sang-Woon Choi, et al.
International Journal of Epidemiology|September 18, 2010
Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysisZhong-Zheng Zhu, Lifang Hou, Valentina Bollati, et al.
Cytotherapy|February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trialsMark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
Blood|June 24, 2009
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignanciesTamer E Fandy, James G Herman, Patrick Kerns, et al.
Pageof 4